Finch Therapeutics Group, Inc. (FNCH)
OTCMKTS · Delayed Price · Currency is USD
13.70
+0.05 (0.40%)
Feb 6, 2026, 4:00 PM EST
Finch Therapeutics Group Market Cap
Finch Therapeutics Group has a market cap or net worth of $22 million as of February 9, 2026. Its market cap has increased by 14.64% in one year.
Market Cap
22.00M
Enterprise Value
34.95M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$13.70
Market Cap Chart
Since March 19, 2021, Finch Therapeutics Group's market cap has decreased from 1.01B to 22.00M, a decrease of -97.81%. That is a compound annual growth rate of -54.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 22.00M | 1.58% |
| Dec 31, 2025 | 21.66M | 19.35% |
| Dec 31, 2024 | 18.15M | 213.02% |
| Dec 29, 2023 | 5.80M | -74.79% |
| Dec 30, 2022 | 22.99M | -95.14% |
| Dec 31, 2021 | 473.36M | -52.91% |
| Mar 19, 2021 | 1.01B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ZIVO Bioscience | 40.77M |
| Arch Biopartners | 38.31M |
| Harvard Apparatus Regenerative Technology | 31.65M |
| Oncotelic Therapeutics | 29.41M |
| EOM Pharmaceuticals Holdings | 17.71M |
| Provectus Biopharmaceuticals | 17.65M |
| Zeo ScientifiX | 15.23M |
| Inhibitor Therapeutics | 13.77M |